Yoon-Jung Cho, MD
Internal Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 30
- 7 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
30 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cho’s office at (408) 249-1212 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
30 of 30 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$9,033
Medicare paid this office $9,033 for 16 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
16 Original Medicare patients in 2024. Average age 77 · Under 65 0% · Health risk score 1.25. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: Diabetes 75% · High blood pressure 69%.
The office billed $21,570, Medicare allowed $11,877 and paid $9,033; for 107 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 16 | 107 | 77 | 1.25 | $21,570 | $9,033 |
| 2023 | 14 | 128 | 74 | 1.14 | $26,735 | $10,630 |
| 2022 | 12 | 71 | 77 | 1.45 | $11,125 | $5,501 |
| 2021 | 15 | 72 | 75 | 1.49 | $10,840 | $5,378 |
| 2019 | 18 | 92 | 77 | 1.64 | $10,430 | $6,231 |
| 2018 | 20 | 56 | 74 | 1.19 | $4,570 | $2,686 |
| 2017 | 17 | 55 | 77 | 1.57 | $5,230 | $2,401 |
| 2016 | 32 | 296 | 76 | 1.41 | $23,550 | $13,905 |
| 2015 | 47 | 267 | 74 | 1.37 | $20,695 | $13,366 |
| 2014 | 135 | 444 | 75 | 1.18 | $31,240 | $20,678 |
| 2013 | 33 | 178 | 70 | 1.38 | $12,325 | $8,328 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 1 service
| Short return visit (20+ min) | 11 | $1,649 | $75 |
2019: 1 service
| Short return visit (20+ min) | 16 | $2,611 | $65 |
2018: 1 service
| Short return visit (20+ min) | 11 | $1,175 | $65 |
2017: 1 service
| Short return visit (20+ min) | 12 | $838 | $49 |
2016: 6 services
| Short return visit (20+ min) | 26 | $6,725 | $64 |
| Short return visit | 19 | $1,851 | $38 |
| Influenza vaccine split virus, preservative free | 13 | $544 | $42 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $396 | $18 |
| Administration of influenza virus vaccine | 12 | $380 | $32 |
| Insertion of needle into vein for collection of blood sample | 22 | $123 | $3 |
2015: 3 services
| Short return visit (20+ min) | 27 | $6,686 | $67 |
| Short return visit | 18 | $1,638 | $41 |
| Insertion of needle into vein for collection of blood sample | 20 | $106 | $3 |
2014: 9 services
| Short return visit (20+ min) | 62 | $7,990 | $63 |
| Short return visit | 46 | $3,113 | $40 |
| New patient visit (15+ min) | 41 | $2,819 | $69 |
| Pneumococcal vaccine, 23-valent | 17 | $666 | $39 |
| Administration of pneumococcal vaccine | 17 | $500 | $29 |
| New patient visit (10+ min) | 12 | $494 | $41 |
| Administration of influenza virus vaccine | 11 | $342 | $31 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 12 | $166 | $14 |
| Insertion of needle into vein for collection of blood sample | 30 | $115 | $3 |
2013: 3 services
| Short return visit (20+ min) | 23 | $4,317 | $69 |
| Short return visit | 24 | $2,187 | $41 |
| Insertion of needle into vein for collection of blood sample | 13 | $56 | $3 |
Medicaid work
$4,141 in 2019
Medicaid paid $4,141 for 138 billed services this clinician did in 2019, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 122 | $4,111 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 16 | $30 |
| 2019 | 138 | 2 | 26 | $4,141 |
| 2018 | 380 | 2 | 28 | $9,641 |
See the largest Medicaid services in earlier years
2018
| Return visit (30+ min) | 312 | $9,508 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 68 | $133 |
Drugs they prescribed that Part D paid
$50,249
Pharmacies billed $50,249 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
389 generic and 45 brand-name prescriptions · $50,249 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 63 | $726 | $12 |
| Rosuvastatin | 18 | $517 | $29 |
| Losartan | 28 | $404 | $14 |
| Levothyroxine | 12 | $316 | $26 |
| Metformin | 25 | $222 | $9 |
See all 6 drugs
| Atorvastatin | 63 | $726 | $12 |
| Rosuvastatin | 18 | $517 | $29 |
| Losartan | 28 | $404 | $14 |
| Levothyroxine | 12 | $316 | $26 |
| Metformin | 25 | $222 | $9 |
| Amlodipine Besylate | 22 | $125 | $6 |
Year by year
| 2024 | 434 | 31 | None | 10% | $50,249 |
| 2023 | 484 | 50 | 2% (11) | None | $115,200 |
| 2022 | 615 | 102 | None | None | $96,941 |
| 2021 | 929 | 138 | None | None | $76,170 |
| 2020 | 896 | 138 | None | None | $61,108 |
| 2019 | 767 | 162 | 2% (18) | None | $62,987 |
| 2018 | 767 | 142 | None | None | $70,997 |
| 2017 | 1,031 | 170 | 2% (20) | 14% | $115,250 |
| 2016 | 1,075 | 136 | 2% (24) | None | $138,521 |
| 2015 | 1,155 | 164 | 2% (22) | None | $116,722 |
| 2014 | 1,418 | 203 | 3% (46) | None | $199,534 |
| 2013 | 1,535 | 149 | 5% (71) | 25% | $257,675 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Atorvastatin | 72 | $1,473 | $20 |
| Diclofenac | 11 | $836 | $76 |
| Ibandronate | 12 | $795 | $66 |
| Losartan | 24 | $444 | $18 |
| Oxybutynin Chloride Er | 11 | $374 | $34 |
| Metformin | 18 | $290 | $16 |
| Amlodipine Besylate | 21 | $288 | $14 |
| Levothyroxine | 11 | $268 | $24 |
| Atenolol | 15 | $225 | $15 |
| Rosuvastatin | 15 | $223 | $15 |
| Omeprazole | 13 | $148 | $11 |
2022: 13 drugs
| Vascepa | 13 | $5,857 | $451 |
| Atorvastatin | 77 | $1,289 | $17 |
| Diclofenac | 14 | $935 | $67 |
| Rosuvastatin | 11 | $791 | $72 |
| Omeprazole | 30 | $573 | $19 |
| Losartan | 31 | $443 | $14 |
| Levothyroxine | 24 | $438 | $18 |
| Metformin | 26 | $371 | $14 |
| Oxybutynin Chloride | 11 | $346 | $31 |
| Atenolol | 12 | $171 | $14 |
| Simvastatin | 13 | $159 | $12 |
| Amlodipine Besylate | 24 | $157 | $7 |
| Metoprolol | 15 | $147 | $10 |
2021: 21 drugs
| Creon | 13 | $25,479 | $1,960 |
| Atorvastatin | 142 | $2,828 | $20 |
| Diclofenac | 32 | $1,505 | $47 |
| Ibandronate | 12 | $1,273 | $106 |
| Acarbose | 14 | $1,148 | $82 |
| Losartan | 42 | $783 | $19 |
| Oxybutynin Chloride | 16 | $746 | $47 |
| Levothyroxine | 28 | $579 | $21 |
| Famotidine | 19 | $509 | $27 |
| Clotrimazole-Betamethasone | 13 | $360 | $28 |
| Metformin | 39 | $343 | $9 |
| Omeprazole | 31 | $331 | $11 |
| Amlodipine Besylate | 27 | $281 | $10 |
| Glipizide | 19 | $208 | $11 |
| Donepezil | 12 | $154 | $13 |
| Metoprolol | 24 | $127 | $5 |
| Gabapentin | 12 | $124 | $10 |
| Potassium Chloride | 11 | $109 | $10 |
| Simvastatin | 11 | $108 | $10 |
| Hydrochlorothiazide | 13 | $84 | $6 |
| Furosemide | 15 | $75 | $5 |
2020: 25 drugs
| Creon | 11 | $24,058 | $2,187 |
| Atorvastatin | 126 | $1,795 | $14 |
| Diclofenac | 25 | $691 | $28 |
| Metoprolol | 13 | $627 | $48 |
| Acarbose | 16 | $613 | $38 |
| Levothyroxine | 30 | $534 | $18 |
| Oxybutynin Chloride | 12 | $490 | $41 |
| Losartan | 38 | $460 | $12 |
| Famotidine | 13 | $440 | $34 |
| Omeprazole | 32 | $435 | $14 |
| Nifedipine Er | 12 | $427 | $36 |
| Clopidogrel | 18 | $392 | $22 |
| Metformin | 40 | $334 | $8 |
| Amitriptyline | 12 | $322 | $27 |
| Pravastatin | 14 | $304 | $22 |
| Amlodipine Besylate | 24 | $275 | $11 |
| Simvastatin | 14 | $212 | $15 |
| Nitroglycerin | 11 | $201 | $18 |
| Meclizine | 13 | $195 | $15 |
| Sertraline | 15 | $139 | $9 |
| Glipizide | 16 | $127 | $8 |
| Potassium Chloride | 13 | $125 | $10 |
| Gabapentin | 11 | $104 | $9 |
| Metoprolol | 19 | $74 | $4 |
| Furosemide | 14 | $55 | $4 |
2019: 19 drugs
| Creon | 14 | $25,461 | $1,819 |
| Atorvastatin | 107 | $2,233 | $21 |
| Nitroglycerin | 17 | $684 | $40 |
| Diclofenac | 14 | $574 | $41 |
| Levothyroxine | 21 | $443 | $21 |
| Ranitidine | 19 | $392 | $21 |
| Metformin | 39 | $363 | $9 |
| Pravastatin | 18 | $341 | $19 |
| Omeprazole | 22 | $333 | $15 |
| Losartan | 33 | $304 | $9 |
| Clopidogrel | 23 | $293 | $13 |
| Amlodipine Besylate | 24 | $225 | $9 |
| Ciprofloxacin | 11 | $181 | $16 |
| Simvastatin | 12 | $120 | $10 |
| Donepezil | 15 | $97 | $6 |
| Atenolol | 12 | $77 | $6 |
| Sertraline | 13 | $74 | $6 |
| Metoprolol | 13 | $73 | $6 |
| Furosemide | 13 | $27 | $2 |
2018: 16 drugs
| Risedronate | 15 | $3,739 | $249 |
| Atorvastatin | 98 | $1,936 | $20 |
| Bystolic | 12 | $1,622 | $135 |
| Ibandronate | 11 | $724 | $66 |
| Losartan | 39 | $519 | $13 |
| Metformin | 51 | $421 | $8 |
| Cefdinir | 11 | $396 | $36 |
| Ranitidine | 21 | $392 | $19 |
| Pravastatin | 18 | $286 | $16 |
| Clopidogrel | 22 | $277 | $13 |
| Omeprazole | 25 | $261 | $10 |
| Levothyroxine | 17 | $256 | $15 |
| Donepezil | 13 | $236 | $18 |
| Amlodipine Besylate | 29 | $227 | $8 |
| Simvastatin | 14 | $95 | $7 |
| Sertraline | 18 | $69 | $4 |
2017: 24 drugs
| Viread | 19 | $20,247 | $1,066 |
| Namenda Xr | 12 | $6,109 | $509 |
| Risedronate | 19 | $5,567 | $293 |
| Atorvastatin | 116 | $3,045 | $26 |
| Bystolic | 13 | $1,554 | $120 |
| Cefdinir | 25 | $1,051 | $42 |
| Losartan | 47 | $952 | $20 |
| Levothyroxine | 32 | $822 | $26 |
| Metoprolol | 11 | $705 | $64 |
| Clopidogrel | 27 | $512 | $19 |
| Pravastatin | 24 | $490 | $20 |
| Donepezil | 30 | $437 | $15 |
| Tamsulosin | 12 | $382 | $32 |
| Metformin | 34 | $364 | $11 |
| Losartan-Hydrochlorothiazide | 12 | $336 | $28 |
| Amlodipine Besylate | 28 | $333 | $12 |
| Ranitidine | 22 | $313 | $14 |
| Metoprolol | 17 | $197 | $12 |
| Simvastatin | 21 | $195 | $9 |
| Atenolol | 17 | $190 | $11 |
| Ciprofloxacin | 15 | $185 | $12 |
| Omeprazole | 17 | $174 | $10 |
| Tramadol | 17 | $168 | $10 |
| Sertraline | 12 | $75 | $6 |
2016: 26 drugs
| Viread | 27 | $27,226 | $1,008 |
| Namenda Xr | 15 | $7,544 | $503 |
| Risedronate | 12 | $3,951 | $329 |
| Omega-3 Acid Ethyl Esters | 19 | $3,789 | $199 |
| Rivastigmine | 13 | $2,967 | $228 |
| Atorvastatin | 91 | $2,033 | $22 |
| Bystolic | 11 | $1,648 | $150 |
| Metoprolol | 11 | $561 | $51 |
| Levothyroxine | 24 | $560 | $23 |
| Cefdinir | 15 | $483 | $32 |
| Losartan | 37 | $452 | $12 |
| Pravastatin | 22 | $443 | $20 |
| Clopidogrel | 22 | $361 | $16 |
| Gabapentin | 20 | $340 | $17 |
| Metformin | 41 | $243 | $6 |
| Omeprazole | 19 | $215 | $11 |
| Amlodipine Besylate | 27 | $211 | $8 |
| Simvastatin | 26 | $200 | $8 |
| Atenolol | 26 | $193 | $7 |
| Losartan-Hydrochlorothiazide | 14 | $190 | $14 |
| Ranitidine | 23 | $177 | $8 |
| Tramadol | 22 | $143 | $7 |
| Carvedilol | 11 | $89 | $8 |
| Hydrochlorothiazide | 18 | $74 | $4 |
| Sertraline | 16 | $73 | $5 |
| Furosemide | 11 | $38 | $3 |
2015: 31 drugs
| Benicar Hct | 11 | $5,980 | $544 |
| Namenda Xr | 16 | $4,233 | $265 |
| Omega-3 Acid Ethyl Esters | 27 | $3,943 | $146 |
| Atorvastatin | 124 | $3,194 | $26 |
| Lamivudine | 12 | $3,141 | $262 |
| Butalbital-Acetaminophen-Caffe | 11 | $1,356 | $123 |
| Voltaren | 14 | $1,239 | $88 |
| Metoprolol | 20 | $832 | $42 |
| Tamsulosin | 13 | $724 | $56 |
| Gabapentin | 19 | $696 | $37 |
| Levothyroxine | 28 | $625 | $22 |
| Losartan | 31 | $608 | $20 |
| Metformin | 61 | $489 | $8 |
| Alendronate | 35 | $413 | $12 |
| Cefdinir | 13 | $407 | $31 |
| Ranitidine | 27 | $394 | $15 |
| Atenolol | 22 | $330 | $15 |
| Simvastatin | 26 | $306 | $12 |
| Losartan-Hydrochlorothiazide | 14 | $275 | $20 |
| Omeprazole | 19 | $238 | $13 |
| Sertraline | 22 | $189 | $9 |
| Amlodipine Besylate | 21 | $163 | $8 |
| Paroxetine | 12 | $139 | $12 |
| Lisinopril | 11 | $128 | $12 |
| Zolpidem | 18 | $121 | $7 |
| Lorazepam | 15 | $117 | $8 |
| Clopidogrel | 12 | $116 | $10 |
| Famotidine | 15 | $111 | $7 |
| Tramadol | 19 | $103 | $5 |
| Carvedilol | 12 | $98 | $8 |
| Hydrochlorothiazide | 28 | $90 | $3 |
2014: 39 drugs
| Lidocaine | 14 | $14,992 | $1,071 |
| Crestor | 20 | $5,908 | $295 |
| Benicar Hct | 13 | $5,599 | $431 |
| Diovan | 11 | $4,462 | $406 |
| Atorvastatin | 145 | $3,717 | $26 |
| Lamivudine | 11 | $3,297 | $300 |
| Dexilant | 11 | $2,320 | $211 |
| Clotrimazole-Betamethasone | 15 | $1,482 | $99 |
| Gabapentin | 20 | $1,157 | $58 |
| Acarbose | 13 | $961 | $74 |
| Tamsulosin | 19 | $939 | $49 |
| Voltaren | 12 | $919 | $77 |
| Cefdinir | 20 | $805 | $40 |
| Metformin | 69 | $768 | $11 |
| Losartan | 36 | $604 | $17 |
| Levothyroxine | 23 | $601 | $26 |
| Nifedipine Er | 15 | $570 | $38 |
| Hydrocodone-Acetaminophen | 19 | $568 | $30 |
| Simvastatin | 31 | $441 | $14 |
| Alendronate | 31 | $384 | $12 |
| Atenolol | 42 | $382 | $9 |
| Omeprazole | 23 | $371 | $16 |
| Clopidogrel | 13 | $342 | $26 |
| Ranitidine | 23 | $321 | $14 |
| Amlodipine Besylate | 33 | $302 | $9 |
| Sertraline | 18 | $293 | $16 |
| Zolpidem | 23 | $250 | $11 |
| Paroxetine | 19 | $222 | $12 |
| Fluticasone Propionate | 11 | $198 | $18 |
| Lorazepam | 18 | $190 | $11 |
| Warfarin | 13 | $165 | $13 |
| Ibuprofen | 14 | $156 | $11 |
| Terazosin | 15 | $153 | $10 |
| Naproxen | 12 | $151 | $13 |
| Metoprolol | 23 | $120 | $5 |
| Ciprofloxacin | 13 | $110 | $8 |
| Tramadol | 13 | $105 | $8 |
| Amoxicillin | 11 | $73 | $7 |
| Hydrochlorothiazide | 11 | $55 | $5 |
2013: 39 drugs
| Lidoderm | 30 | $35,909 | $1,197 |
| Forteo | 23 | $29,460 | $1,281 |
| Creon | 14 | $9,017 | $644 |
| Celebrex | 21 | $8,678 | $413 |
| Atorvastatin | 135 | $6,686 | $50 |
| Lamivudine | 20 | $4,953 | $248 |
| Effexor Xr | 11 | $4,132 | $376 |
| Proair Hfa | 14 | $1,883 | $134 |
| Clopidogrel | 17 | $1,648 | $97 |
| Voltaren | 23 | $1,553 | $68 |
| Oxycodone | 12 | $1,250 | $104 |
| Cefdinir | 24 | $1,214 | $51 |
| Mometasone Furoate | 14 | $1,057 | $76 |
| Oxycodone Hcl-Acetaminophen | 11 | $1,046 | $95 |
| Gabapentin | 16 | $999 | $62 |
| Clotrimazole-Betamethasone | 15 | $968 | $65 |
| Lansoprazole | 14 | $909 | $65 |
| Losartan | 37 | $871 | $24 |
| Omeprazole | 35 | $734 | $21 |
| Metformin | 62 | $726 | $12 |
| Tamsulosin | 17 | $694 | $41 |
| Acarbose | 13 | $603 | $46 |
| Simvastatin | 36 | $553 | $15 |
| Hydrocodone-Acetaminophen | 37 | $547 | $15 |
| Isosorbide Mononitrate Er | 14 | $496 | $35 |
| Carvedilol | 17 | $480 | $28 |
| Levothyroxine | 31 | $474 | $15 |
| Sulindac | 12 | $427 | $36 |
| Atenolol | 47 | $393 | $8 |
| Doxazosin Mesylate | 11 | $371 | $34 |
| Alendronate | 24 | $368 | $15 |
| Amlodipine Besylate | 30 | $355 | $12 |
| Sertraline | 13 | $314 | $24 |
| Ranitidine | 19 | $305 | $16 |
| Warfarin | 19 | $290 | $15 |
| Metoprolol | 28 | $235 | $8 |
| Ibuprofen | 15 | $214 | $14 |
| Triamcinolone Acetonide | 14 | $156 | $11 |
| Zolpidem | 22 | $135 | $6 |
Money from drug and device companies
$319 in 2025
| 2025 | 1 | 38 | None | $319 |
| 2024 | 1 | 22 | None | $237 |
| 2023 | 2 | 2 | None | $39 |
| 2022 | 1 | 1 | None | $13 |
| 2021 | 1 | 1 | None | $26 |
| 2020 | 2 | 4 | None | $66 |
| 2019 | 2 | 16 | None | $139 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Linzess | $319 | 38 payments
|
See all 38 published payments
| Abbvie | Meals · 2025-12-02 | Linzess | $10 |
| Abbvie | Meals · 2025-11-19 | Linzess | $10 |
| Abbvie | Meals · 2025-11-04 | Linzess | $1 |
| Abbvie | Meals · 2025-11-04 | Creon | $7 |
| Abbvie | Meals · 2025-10-23 | Creon | $10 |
| Abbvie | Meals · 2025-10-16 | Linzess | $9 |
| Abbvie | Meals · 2025-10-07 | Linzess | $9 |
| Abbvie | Meals · 2025-09-23 | Linzess | $7 |
| Abbvie | Meals · 2025-09-18 | Linzess | $9 |
| Abbvie | Meals · 2025-09-08 | Linzess | $9 |
| Abbvie | Meals · 2025-09-04 | Linzess | $9 |
| Abbvie | Meals · 2025-08-25 | Linzess | $8 |
| Abbvie | Meals · 2025-08-21 | Linzess | $9 |
| Abbvie | Meals · 2025-08-12 | Linzess | $9 |
| Abbvie | Meals · 2025-07-29 | Creon | $10 |
| Abbvie | Meals · 2025-07-21 | Linzess | $7 |
| Abbvie | Meals · 2025-07-16 | Creon | $10 |
| Abbvie | Meals · 2025-07-10 | Linzess | $10 |
| Abbvie | Meals · 2025-06-26 | Creon | $10 |
| Abbvie | Meals · 2025-06-17 | Creon | $7 |
| Abbvie | Meals · 2025-06-12 | Creon | $8 |
| Abbvie | Meals · 2025-06-03 | Linzess | $9 |
| Abbvie | Meals · 2025-05-28 | Linzess | $9 |
| Abbvie | Meals · 2025-05-22 | Creon | $8 |
| Abbvie | Meals · 2025-05-15 | Linzess | $9 |
| Abbvie | Meals · 2025-05-05 | Creon | $8 |
| Abbvie | Meals · 2025-05-01 | Linzess | $8 |
| Abbvie | Meals · 2025-04-22 | Creon | $9 |
| Abbvie | Meals · 2025-04-10 | Linzess | $7 |
| Abbvie | Meals · 2025-03-29 | Creon | $8 |
| Abbvie | Meals · 2025-03-21 | Creon | $9 |
| Abbvie | Meals · 2025-03-11 | Creon | $8 |
| Abbvie | Meals · 2025-02-28 | Creon | $8 |
| Abbvie | Meals · 2025-02-10 | Creon | $9 |
| Abbvie | Meals · 2025-02-04 | Creon | $8 |
| Abbvie | Meals · 2025-01-24 | Linzess | $8 |
| Abbvie | Meals · 2025-01-14 | Creon | $9 |
| Abbvie | Meals · 2025-01-07 | Creon | $10 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $237
| Abbvie | Linzess | $237 | 22 payments
|
2023: $39
| Astellas Pharma US | Veozah | $24 | 1 payment
|
| GlaxoSmithKline | Shingrix | $15 | 1 payment
|
2022: $13
| Abbvie | Creon | $13 | 1 payment
|
2021: $26
| Gilead Sciences | None | $26 | 1 payment
|
2020: $66
| Gilead Sciences | None | $55 | 3 payments
|
| Sanofi Pasteur | Fluzone Quadrivalent | $11 | 1 payment
|
2019: $139
| Gilead Sciences | None | $116 | 15 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $24 | 1 payment
|
Professional record
- NPI
- 1447330394
- Licence
- CA A054133
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2344 El Camino Real, 105, Santa Clara, CA, 95050
- NPI first listed
- 2006-10-16
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.